NFKB1 and nasopharyngeal carcinoma: In lymphoma and nasopharyngeal carcinoma, EBV strains with LMP-1 del30 mutation have higher tumorigenicity than strains without deletion [39], which enhances the transduction ability of EBV without affecting the NF-κB signaling pathway [36].